[144] Willdan Group, Inc. SEC Filing
Willdan Group, Inc. (WLDN) Form 144 shows proposed sale of 5,182 common shares through Morgan Stanley Smith Barney on 08/25/2025 with an aggregate market value of $612,256.41. The shares were acquired and paid for the same day by stock option exercise with cash payment. The filing lists recent sales by the same seller, Thomas Brisbin, including 117,595 shares on 08/22/2025 for $12,784,328.67 and 125,000 shares on 08/21/2025 for $13,052,878.66, among other transactions. The form states the seller represents no undisclosed material adverse information.
- Form 144 was filed, documenting proposed sale in compliance with Rule 144 requirements
- Securities to be sold were acquired by stock option exercise and paid for in cash on the same date
- Multiple large insider sales by Thomas Brisbin in August 2025, including 125,000 and 117,595 share blocks that generated multi-million dollar proceeds
- Filing provides no disclosure of a 10b5-1 trading plan or additional context explaining the timing of concentrated sales
Insights
TL;DR Significant insider sales were reported over several days; a small proposed sale on 08/25/2025 follows option exercise.
The filing documents a proposed sale of 5,182 shares resulting from a same-day stock option exercise and paid in cash, which is routine for option holders monetizing gains. However, the record shows multiple large dispositions by Thomas Brisbin in August 2025, including two blocks of 125,000 and 117,595 shares, generating multi-million dollar proceeds. Such concentrated insider sales over a short period are material to investors because they can affect free float and market perception. The filing itself contains no forward-looking statements or explanations for the timing of these sales.
TL;DR The filer complied with Rule 144 disclosure; transactions are documented but no context on trading plan is provided.
Form 144 appears properly completed for the proposed sale and discloses acquisition method (stock option exercise) and payment in cash. The seller affirms lack of undisclosed material adverse information. The filing does not state adoption of a trading plan under Rule 10b5-1 or provide additional governance context, so while procedurally compliant, it offers limited insight into intent or company-level governance implications.